| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 43,186 | 43,068 | 43,325 | 43,928 | | Cost of Revenue | (25,261) | 12,670 | 12,591 | 12,815 | | | Gross Profit | 68,447 | 30,398 | 30,734 | 31,113 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 40,242 | 2,166 | 2,561 | 2,198 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 13,587 | 13,310 | 13,044 | 12,793 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 14,618 | 14,922 | 15,129 | 16,122 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 81 | 39 | 132 | 112 | | Earnings Before Interest And Taxes | 14,536 | 15,043 | 15,342 | 16,147 | | Interest Expense | 8,537 | 7,817 | 7,501 | 7,714 | | Income Before Tax | 5,999 | 7,226 | 7,841 | 8,433 | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest | (97) | (70) | (163) | (164) | | | | Net Income From Continuing Ops | 6,477 | 7,156 | 7,678 | 8,433 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 6,147 | 7,156 | 7,678 | 8,433 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $6,147 | $7,156 | $7,678 | $8,433 |
|
0.51% Nasdaq 
Income Statement
